The Ministry of Rural Development (MRD) will soon commence spot monitoring of Constituency Development Funds (CDF) projects in all the 50 constituencies. This is to gauge the level of project ...

Shares of Exact Sciences Corp. (EXAS) traded over 2% higher on Tuesday afternoon after the company launched a new test ...

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the expansion of its ...

Corp announced the launch of Oncodetecta-a new test designed to detect molecular residual disease, MRD, across multiple ...

Renovaro Inc. (NASDAQ: RENB) , an AI-driven precision Medicine Company that leverages AI platforms to improve outcomes for cancer and neurologically challenged patients, today announced is expanding ...

The Oncodetect test detects molecular residual disease across solid tumors using circulating tumor DNA to inform recurrence ...

The North American minimal residual disease (MRD) testing market is poised for substantial growth in the coming years. With a projected annual increase of 11.1% throughout the forecast period, ...

Marc Raab, MD, PhD, discussed the MajesTEC-5 trial of teclistamab plus standard myeloma therapies in transplant-eligible ...

Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced the launch of Oncodetect™—a new test designed to detect molecular residual disease ...

The test can detect residual cancer cells (Minimal Residual Disease – MRD) after radical treatment predict recurr ...